Medicenna Therapeutics announced that its investigational drug MDNA209, designed to block CD122 and suppress overactive immune cells, significantly extended survival by 3-4 times in mouse models of acute graft-versus-host disease (aGvHD). The drug binds tightly to CD122, inhibiting IL-2 and IL-15 signaling pathways involved in autoimmune diseases, and demonstrated potent immune cell suppression without harming regulatory T cells. These promising preclinical results highlight MDNA209's potential as a novel treatment for autoimmune diseases, with Medicenna exploring partnerships and further development. This differentiates MDNA209 from existing anti-CD122 antibodies by its ability to fine-tune immune signaling for disease-specific therapies.
Medicenna's MDNA209 preclinical results provide context for readers interested in innovative autoimmune treatments. For readers following the Health sector, here is Pluang's market snapshot as of Oct 26, 2026 19:02 WIB: Among 150 priced US Health stocks, 78 rose and 48 fell today. AbCellera Biologics Inc (ABCL) gained 1.52% to USD 12.00 with a typical hold time of 41 days, DENTSPLY SIRONA Inc (XRAY) rose 1.48% to USD 9.57 with a 73-day hold, while Iovance Biotherapeutics Inc (IOVA) increased 1.42% to USD 14.29 but had a much shorter typical hold time of 4 days.
Senseonics Holdings has begun the first human clinical trial of Freedom, a next-generation continuous glucose monitoring (CGM) system designed without an external on-body transmitter. This implantable device communicates directly with mobile devices ...
Stryker Corporation has finalized its acquisition of ZuriMED, incorporating the FiberLocker System into its Sports Medicine offerings. This technology enhances rotator cuff repair by improving biomechanical strength, addressing a key clinical need. T...
Kratos Defense & Security Solutions announced it will release its third quarter 2026 financial results after market close on November 5, 2026. The company will hold a conference call at 2:00 p.m. Pacific Time to discuss its operations and financial p...
FOREWARN, a safety solutions provider for real estate professionals, introduced Community Alerts, a new feature that allows agents to flag phone numbers after concerning interactions. This alert is instantly shared across its network of over 443,000 ...
Franklin Electric Co., Inc. announced a quarterly cash dividend of $0.28 per share, payable on November 19, 2026, to shareholders of record as of November 5, 2026. This dividend reflects the company's ongoing commitment to returning value to its shar...
